Exosome RNA Exosome RNA Research & Industry News

Due to the critical limitations of conventional antitumor agents, great efforts have been made to develop advanced drug delivery systems to enhance the therapeutic outcomes of antitumor drugs, reduce...

EXO Biologics is a clinical-stage biotechnology company focusing on developing innovative extracellular vesicles treatments. Our mission is to provide affordable and accessible extracellular vesicles (EVs) therapies to patients with unmet medical ...

Nano-sized membrane bubbles known as extracellular vesicles activate the immune system in mice and seem to render their tumours sensitive to a type of immunotherapy drug called a checkpoint...

Osteosarcoma, a primary malignant tumor of the skeleton, has a morbidity of 2.5 per 1 million people. The epiphysis of extremities is typically affected...

The conventional manufacturing of extracellular vesicles (EVs) is characterized by low yields and batch-to-batch variability, hampering fundamental research on EVs and their practical applications...

This annual conference brings together academics and industry participants from around the world focused on research, biomarker analyses and therapeutics development leveraging the cargo...

An aptamer-based field-effect transistor (Apta-FET) is a well-developed assay method with high selectivity and sensitivity. Due to the limited information density that natural nucleotide library holds...

Exosomes have come to the fore in drug delivery systems due to their biological-based and immune-suppressing properties. Researchers at Aydin Adnan Menderes University investigated the effect of...

Characterizing sources and targets of illumination in living tissue is challenging. MIT researchers show that spatial distributions of light in tissue can be...

Breast cancer (BC) is one of the most frequent malignancies among women worldwide. Accumulating evidence indicates that long non-coding RNA (lncRNA) may affect BC progression...